Medical News

RSS

Green Cross seeks regulatory approval for peramivir in S.Korea

BioCryst Pharmaceuticals, Inc. today announced that it has been informed by its partner, Green Cross Corp., that Green Cross has filed a New Drug Application (NDA) in South Korea to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza.

9 Jan 2010

ChiroCode Institute and Avazzia jointly promote advanced technology devices

ChiroCode Institute and Avazzia will jointly promote advanced technology devices that help chiropractors and other caregivers manage their patients' chronic pain. The Avazzia BEST Pro Sport device combines microcurrent transcutaneous stimulation with somatic bio-feedback to provide improved results while making obsolete existing TENS devices.

9 Jan 2010

CCAGW calls for open, televised process on healthcare negotiations

The Council for Citizens Against Government Waste (CCAGW) today called upon Congress and the Obama administration to open the doors and allow taxpayers to view all of the proceedings related to negotiations over the healthcare reform bill.

9 Jan 2010

FIER CPVC-Montreal LP offers a loan of $500,000 to Aptilon

Aptilon Corporation ("Aptilon" or the "Corporation"), an innovative leader of on-line marketing services to physicians, today announced that it has obtained a $500,000 loan (the "Loan") from FIER CPVC-Montreal LP (the "FIER").

9 Jan 2010

Harvard Pilgrim Health Care wins contract to develop a pilot of FDA's Sentinel System

The U.S. Food and Drug Administration has awarded a contract to Harvard Pilgrim Health Care Inc. to develop a pilot of the FDA's Sentinel System, which will use automated health care data to evaluate medical product safety.

9 Jan 2010

Cytori Therapeutics' PureGraft System receives FDA marketing clearance

The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient’s own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.

9 Jan 2010

Seven new biopharmaceutical companies join PhRMA, Forbes reports

Forbes recently reported that seven new biopharmaceutical companies have now joined the Pharmaceutical Research and Manufacturers of America (PhRMA).

From CSL Ltd 9 Jan 2010

Primer: House vs. Senate health bill

"Most of the two bills' provisions are similar, and the cost estimates are in the range Democrats have sought. According to the nonpartisan Congressional Budget Office, the House bill would reduce the federal deficit by $130 billion over the next 10 years, while the Senate would cut it $132 billion. Some difficult controversies remain.

9 Jan 2010

Study: Reform bills could save health care dollars

The Los Angeles Times: "National healthcare legislation in Congress could slow the growth of medical costs, allowing employers to create 250,000 to 400,000 new jobs a year over the next decade, economists from Harvard University and USC are predicting.

9 Jan 2010

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

9 Jan 2010

Centron receives agency of record assignments for FRAGMIN and GLIADEL Wafer medicines

HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.

9 Jan 2010

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.

9 Jan 2010

Study finds patients more likely to skip diabetes medicine while in the 'doughnut hole'

Consumers experiencing a gap in their Medicare Part D prescription drug coverage were more likely to forgo diabetes medications than those who had supplemental drug benefits.

9 Jan 2010

LehmanMillet honored with four prestigious industry awards

HealthSTAR's LehmanMillet, the leading agency devoted to working with health care companies changing standards of care, today announced it has won four prestigious industry awards: an MM&M (Medical Marketing & Media Magazine) Gold Award for work done on behalf of Abbott Nutrition; a First Place DxMA (Diagnostic Marketing Association) award for work done on behalf of Abbott Diagnostics; a First Place DxMA Award for work done on behalf of BRAHMS USA; and a PM360 Pharma Choice Bronze Award.

9 Jan 2010

Today's opinions and editorials

Californians need to ask themselves why, when other states and the federal government are making children's health a priority, the Golden State may be adding another half-million children … to the ranks of the uninsured next year (1/7).

9 Jan 2010

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Svelte Medical Systems, Inc. is pleased to announce that it has initiated its European clinical trial at the Thoraxcenter Research Center in Rotterdam, the Netherlands for its “Stent-on-a-Wire” (SOAW) cobalt–chromium Bare Metal Stent.

9 Jan 2010

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUS® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.

9 Jan 2010

Economist examines innovative mechanisms for funding global health programs

The Economist examines the "dramatic" change in funding for projects aimed at fighting diseases in the developing world. "In 1990 more than two-thirds of the $5.6 billion spent on global health assistance came from governments.

9 Jan 2010

Labopharm settles $1 million standby equity distribution with YA Global Master SPV

Labopharm Inc. today announced it has settled the previously announced draw down of $1 million under its standby equity distribution (SEDA) with YA Global Master SPV Ltd. (YA). Under the draw down, Labopharm issued 482,165 of its common shares to YA at a price of $2.07 per common share, net of the applicable discount. (All currency figures are in Canadian dollars.)

9 Jan 2010

Trim Holding Group purchases patent rights under patent agreement with Allkey

Trim Holding Group ("the Company") announced that on December 31, 2009 the Company purchased patent rights under a patent agreement signed with Allkey Ltd. In consideration of the patent rights, the Company issued 3,750,000 preferred shares with a par value of $7.00/share.

9 Jan 2010